The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
John G.F. Cleland, M.D., Jean-Claude Daubert, M.D., Erland Erdmann, M.D., Nick Freemantle, Ph.D., Daniel Gras, M.D., Lukas Kappenberger, M.D., Luigi Tavazzi, M.D., for the Cardiac Resynchronization Heart Failure (CARE-HF) Study Investigators
Background Cardiac resynchronization reduces symptoms and improvesleft ventricular function in many patients with heart failuredue to left ventricular systolic dysfunction and cardiac dyssynchrony.We evaluated its effects on morbidity and mortality.
Methods Patients with New York Heart Association class III orIV heart failure due to left ventricular systolic dysfunctionand cardiac dyssynchrony who were receiving standard pharmacologictherapy were randomly assigned to receive medical therapy aloneor with cardiac resynchronization. The primary end point wasthe time to death from any cause or an unplanned hospitalizationfor a major cardiovascular event. The principal secondary endpoint was death from any cause.
Results A total of 813 patients were enrolled and followed fora mean of 29.4 months. The primary end point was reached by159 patients in the cardiac-resynchronization group, as comparedwith 224 patients in the medical-therapy group (39 percent vs.55 percent; hazard ratio, 0.63; 95 percent confidence interval,0.51 to 0.77; P<0.001). There were 82 deaths in the cardiac-resynchronizationgroup, as compared with 120 in the medical-therapy group (20percent vs. 30 percent; hazard ratio 0.64; 95 percent confidenceinterval, 0.48 to 0.85; P<0.002). As compared with medicaltherapy, cardiac resynchronization reduced the interventricularmechanical delay, the end-systolic volume index, and the areaof the mitral regurgitant jet; increased the left ventricularejection fraction; and improved symptoms and the quality oflife (P<0.01 for all comparisons).
Conclusions In patients with heart failure and cardiac dyssynchrony,cardiac resynchronization improves symptoms and the qualityof life and reduces complications and the risk of death. Thesebenefits are in addition to those afforded by standard pharmacologictherapy. The implantation of a cardiac-resynchronization deviceshould routinely be considered in such patients.
Source Information
From the Department of Cardiology, Castle Hill Hospital, Kingston-upon-Hull, United Kingdom (J.G.F.C.); the Department of Cardiology, Hôpital Pontchaillou, Rennes, France (J.-C.D.); Klinik III für Innere Medizin der Universität zu Köln, Cologne, Germany (E.E.); the University of Birmingham, Edgbaston, United Kingdom (N.F.); Nouvelles Cliniques Nantaises, Nantes, France (D.G.); the Division of Cardiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (L.K.); and Istituto di Ricovero e Cura a Carattere Scientifico, Policlinico San Matteo, Pavia, Italy (L.T.). This article was published at www.nejm.org on March 7, 2004.
Address reprint requests to Dr. Cleland at the Department of Cardiology, Castle Hill Hospital, University of Hull, Kingston-upon-Hull, United Kingdom, or at j.g.cleland{at}hull.ac.uk.
Thomas, D. E., Wheeler, R., Yousef, Z. R., Masani, N. D.
(2009). The role of echocardiography in guiding management in dilated cardiomyopathy. Eur J Echocardiogr
10: iii15-iii21
[Abstract][Full Text]
Mehta, P A, Dubrey, S W, McIntyre, H F, Walker, D M, Hardman, S M C, Sutton, G C, McDonagh, T A, Cowie, M. R
(2009). Improving survival in the 6 months after diagnosis of heart failure in the past decade: population-based data from the UK. Heart
95: 1851-1856
[Abstract][Full Text]
Cleland, J. G., McMurray, J. J.V., Kjekshus, J., Cornel, J. H., Dunselman, P., Fonseca, C., Hjalmarson, A., Korewicki, J., Lindberg, M., Ranjith, N., van Veldhuisen, D. J., Waagstein, F., Wedel, H., Wikstrand, J., on behalf of the CORONA Study Group,
(2009). Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).. J Am Coll Cardiol
54: 1850-1859
[Abstract][Full Text]
Daubert, C., Gold, M. R., Abraham, W. T., Ghio, S., Hassager, C., Goode, G., Szili-Torok, T., Linde, C., on behalf of the REVERSE Study Group,
(2009). Prevention of Disease Progression by Cardiac Resynchronization Therapy in Patients With Asymptomatic or Mildly Symptomatic Left Ventricular Dysfunction: Insights From the European Cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) Trial. J Am Coll Cardiol
54: 1837-1846
[Abstract][Full Text]
Exner, D. V.
(2009). Is it Time to Expand the Use of Cardiac Resynchronization Therapy to Patients With Mildly Symptomatic Heart Failure?. J Am Coll Cardiol
54: 1847-1849
[Full Text]
St. John Sutton, M., Ghio, S., Plappert, T., Tavazzi, L., Scelsi, L., Daubert, C., Abraham, W. T., Gold, M. R., Hassager, C., Herre, J. M., Linde, C., on Behalf of the REsynchronization reVErses Remode,
(2009). Cardiac Resynchronization Induces Major Structural and Functional Reverse Remodeling in Patients With New York Heart Association Class I/II Heart Failure. Circulation
120: 1858-1865
[Abstract][Full Text]
Francis, G. S., Wilson Tang, W.H.
(2009). Early Cardiac Resynchronization Therapy and Reverse Remodeling in Patients With Mild Heart Failure: Is It Time?. Circulation
120: 1845-1846
[Full Text]
Cabrera-Bueno, F., Fernandez-Pastor, J., Molina-Mora, M. J., Alzueta, J., Pena-Hernandez, J. L., Barrera, A., de Teresa-Galvan, E.
(2009). Combined resynchronization therapy and automatic defibrillator in advanced non-ischaemic heart failure: the importance of QRS width. Europace
0: eup348v1-eup348
[Abstract][Full Text]
Kamdar, R., Frain, E., Warburton, F., Richmond, L., Mullan, V., Berriman, T., Thomas, G., Tenkorang, J., Dhinoja, M., Earley, M., Sporton, S., Schilling, R.
(2009). A prospective comparison of echocardiography and device algorithms for atrioventricular and interventricular interval optimization in cardiac resynchronization therapy. Europace
0: eup337v1-eup337
[Abstract][Full Text]
Breithardt, G.
(2009). MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy): cardiac resynchronization therapy towards early management of heart failure. Eur Heart J
30: 2551-2553
[Full Text]
van Veldhuisen, D. J., Maass, A. H., Priori, S. G., Stolt, P., van Gelder, I. C., Dickstein, K., Swedberg, K.
(2009). Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail
0: hfp149v1-hfp149
[Abstract][Full Text]
Muellerleile, K., Baholli, L., Groth, M., Barmeyer, A. A., Koopmann, K., Ventura, R., Koester, R., Adam, G., Willems, S., Lund, G. K.
(2009). Interventricular Mechanical Dyssynchrony: Quantification with Velocity-encoded MR Imaging. Radiology
253: 364-371
[Abstract][Full Text]
Sciaraffia, E., Malmborg, H., Lonnerholm, S., Blomstrom, P., Blomstrom Lundqvist, C.
(2009). Right ventricular contractility as a measure of optimal interventricular pacing setting in cardiac resynchronization therapy. Europace
11: 1496-1500
[Abstract][Full Text]
Gasparini, M., Regoli, F., Galimberti, P., Ceriotti, C., Cappelleri, A.
(2009). Cardiac resynchronization therapy in heart failure patients with atrial fibrillation. Europace
11: v82-v86
[Abstract][Full Text]
Bertini, M., Delgado, V., Bax, J. J., Van de Veire, N. R.L.
(2009). Why, how and when do we need to optimize the setting of cardiac resynchronization therapy?. Europace
11: v46-v57
[Abstract][Full Text]
Leclercq, C.
(2009). Problems and troubleshooting in regular follow-up of patients with cardiac resynchronization therapy. Europace
11: v66-v71
[Abstract][Full Text]
Sanaa, I., Franceschi, F., Prevot, S., Bastard, E., Deharo, J.-C.
(2009). Is there a need for more than one left ventricular lead in some patients?. Europace
11: v29-v31
[Abstract][Full Text]
Daubert, J. C., Leclercq, C., Mabo, P.
(2009). Cardiac resynchronization therapy in combination with implantable cardioverter-defibrillator. Europace
11: v87-v92
[Abstract][Full Text]
Foley, P. W.X., Leyva, F., Frenneaux, M. P.
(2009). What is treatment success in cardiac resynchronization therapy?. Europace
11: v58-v65
[Abstract][Full Text]
Romeyer-Bouchard, C., Da Costa, A., Dauphinot, V., Messier, M., Bisch, L., Samuel, B., Lafond, P., Ricci, P., Isaaz, K.
(2009). Prevalence and risk factors related to infections of cardiac resynchronization therapy devices. Eur Heart J
0: ehp421v1-ehp421
[Abstract][Full Text]
Williams, L. K., Ellery, S., Patel, K., Leyva, F., Bleasdale, R. A., Phan, T. T., Stegemann, B., Paul, V., Steendijk, P., Frenneaux, M.
(2009). Short-Term Hemodynamic Effects of Cardiac Resynchronization Therapy in Patients With Heart Failure, a Narrow QRS Duration, and No Dyssynchrony. Circulation
120: 1687-1694
[Abstract][Full Text]
Smiseth, O. A., Russell, K., Remme, E. W.
(2009). Pacing in Heart Failure Patients With Narrow QRS: Is There More to Gain Than Resynchronization?. Circulation
120: 1651-1653
[Full Text]
Suzuki, S., Furui, S., Yamakawa, T., Isshiki, T., Watanabe, A., Iino, R., Kidouchi, T., Nakano, Y.
(2009). Radiation exposure to patients' skin during cardiac resynchronization therapy. Europace
0: eup302v1-eup302
[Abstract][Full Text]
Penicka, M., Linkova, H., Lang, O., Fojt, R., Kocka, V., Vanderheyden, M., Bartunek, J.
(2009). Predictors of Improvement of Unrepaired Moderate Ischemic Mitral Regurgitation in Patients Undergoing Elective Isolated Coronary Artery Bypass Graft Surgery. Circulation
120: 1474-1481
[Abstract][Full Text]
van Bommel, R. J., Bax, J. J., Abraham, W. T., Chung, E. S., Pires, L. A., Tavazzi, L., Zimetbaum, P. J., Gerritse, B., Kristiansen, N., Ghio, S.
(2009). Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis. Eur Heart J
30: 2470-2477
[Abstract][Full Text]
Dickstein, K., Bogale, N., Priori, S., Auricchio, A., Cleland, J. G., Gitt, A., Limbourg, T., Linde, C., van Veldhuisen, D. J., Brugada, J., on behalf of the Scientific Committee and National,
(2009). The European cardiac resynchronization therapy survey. Eur Heart J
30: 2450-2460
[Abstract][Full Text]
Steffel, J., Hurlimann, D.
(2009). Current practice of cardiac resynchronization therapy (CRT) in the real world: insights from the European CRT survey. Eur Heart J
30: 2433-2435
[Full Text]
Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., Estes, N.A. M. III, Foster, E., Greenberg, H., Higgins, S. L., Pfeffer, M. A., Solomon, S. D., Wilber, D., Zareba, W., the MADIT-CRT Trial Investigators,
(2009). Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events. NEJM
361: 1329-1338
[Abstract][Full Text]
Tanaka, H., Kawai, H., Tatsumi, K., Kataoka, T., Onishi, T., Yoshida, A., Hirata, K.-i.
(2009). Large response to cardiac resynchronization therapy in a patient with segmental paradoxical systolic expansion identified by strain imaging. Eur J Echocardiogr
10: 889-892
[Abstract][Full Text]
Leyva, F, Foley, P W X, Stegemann, B, Ward, J A, Ng, L L, Frenneaux, M P, Regoli, F, Smith, R E A, Auricchio, A
(2009). Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy. Heart
95: 1619-1625
[Abstract][Full Text]
Patwala, A., Woods, P., Clements, R., Albouaini, K., Rao, A., Goldspink, D., Tan, L.-B., Oo, A., Wright, D.
(2009). A prospective longitudinal evaluation of the benefits of epicardial lead placement for cardiac resynchronization therapy. Europace
11: 1323-1329
[Abstract][Full Text]
Bonakdar, H. R., Jorat, M. V., Fazelifar, A. F., Alizadeh, A., Givtaj, N., Sameie, N., Sadeghpour, A., Haghjoo, M.
(2009). Prediction of response to cardiac resynchronization therapy using simple electrocardiographic and echocardiographic tools. Europace
11: 1330-1337
[Abstract][Full Text]
Bertini, M., Marsan, N. A., Delgado, V., van Bommel, R. J., Nucifora, G., Borleffs, C. J. W., Boriani, G., Biffi, M., Holman, E. R., van der Wall, E. E., Schalij, M. J., Bax, J. J.
(2009). Effects of cardiac resynchronization therapy on left ventricular twist.. J Am Coll Cardiol
54: 1317-1325
[Abstract][Full Text]
Singh, J. P., Rosenthal, L. S., Hranitzky, P. M., Berg, K. C., Mullin, C. M., Thackeray, L., Kaplan, A.
(2009). Device diagnostics and long-term clinical outcome in patients receiving cardiac resynchronization therapy. Europace
0: eup250v1-eup250
[Abstract][Full Text]
Santaularia-Tomas, M., Abraham, T. P.
(2009). Criteria predicting response to CRT: is more better?. Eur Heart J
0: ehp378v1-ehp378
[Full Text]
Boriani, G., Gasparini, M., Landolina, M., Lunati, M., Biffi, M., Santini, M., Padeletti, L., Molon, G., Botto, G., De Santo, T., Valsecchi, S., on behalf of the InSync/InSync ICD Italian Registr,
(2009). Effectiveness of cardiac resynchronization therapy in heart failure patients with valvular heart disease: comparison with patients affected by ischaemic heart disease or dilated cardiomyopathy. The InSync/InSync ICD Italian Registry. Eur Heart J
30: 2275-2283
[Abstract][Full Text]
Berger, R., Shankar, A., Fruhwald, F., Fahrleitner-Pammer, A., Freemantle, N., Tavazzi, L., Cleland, J. G.F., Pacher, R.
(2009). Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study. Eur Heart J
30: 2109-2116
[Abstract][Full Text]
De Boeck, B. W.L., Teske, A. J., Meine, M., Leenders, G. E., Cramer, M. J., Prinzen, F. W., Doevendans, P. A.
(2009). Septal rebound stretch reflects the functional substrate to cardiac resynchronization therapy and predicts volumetric and neurohormonal response. Eur J Heart Fail
11: 863-871
[Abstract][Full Text]
Stahlberg, M., Damgaard, M., Norsk, P., Gabrielsen, A., Sahlen, A., Linde, C., Braunschweig, F.
(2009). Cardiac output response to changes of the atrioventricular delay in different body positions and during exercise in patients receiving cardiac resynchronization therapy. Europace
11: 1160-1167
[Abstract][Full Text]
Kronborg, M. B., Albertsen, A. E., Nielsen, J. C., Mortensen, P. T.
(2009). Long-term clinical outcome and left ventricular lead position in cardiac resynchronization therapy. Europace
11: 1177-1182
[Abstract][Full Text]
Marcus, G. M., Keung, E., Scheinman, M. M.
(2009). The year in review of clinical cardiac electrophysiology.. J Am Coll Cardiol
54: 777-787
[Full Text]
Hsich, E. M., Pina, I. L.
(2009). Heart failure in women: a need for prospective data.. J Am Coll Cardiol
54: 491-498
[Abstract][Full Text]
Biffi, M., Moschini, C., Bertini, M., Saporito, D., Ziacchi, M., Diemberger, I., Valzania, C., Domenichini, G., Cervi, E., Martignani, C., Sangiorgi, D., Branzi, A., Boriani, G.
(2009). Phrenic Stimulation: A Challenge for Cardiac Resynchronization Therapy. Circ Arrhythm Electrophysiol
2: 402-410
[Abstract][Full Text]
Barth, A. S., Aiba, T., Halperin, V., DiSilvestre, D., Chakir, K., Colantuoni, C., Tunin, R. S., Dimaano, V. L., Yu, W., Abraham, T. P., Kass, D. A., Tomaselli, G. F.
(2009). Cardiac Resynchronization Therapy Corrects Dyssynchrony-Induced Regional Gene Expression Changes on a Genomic Level. Circ Cardiovasc Genet
2: 371-378
[Abstract][Full Text]
Thomas, D. E., Yousef, Z. R., Fraser, A. G.
(2009). A critical comparison of echocardiographic measurements used for optimizing cardiac resynchronization therapy: stroke distance is best. Eur J Heart Fail
11: 779-788
[Abstract][Full Text]
Schmidt, M., Rittger, H., Marschang, H., Sinha, A.-M., Daccarett, M., Brachmann, J., Block, M., Breithardt, O. A.
(2009). Left ventricular dyssynchrony from right ventricular pacing depends on intraventricular conduction pattern in intrinsic rhythm. Eur J Echocardiogr
10: 776-783
[Abstract][Full Text]
Schofer, J., Siminiak, T., Haude, M., Herrman, J. P., Vainer, J., Wu, J. C., Levy, W. C., Mauri, L., Feldman, T., Kwong, R. Y., Kaye, D. M., Duffy, S. J., Tubler, T., Degen, H., Brandt, M. C., Van Bibber, R., Goldberg, S., Reuter, D. G., Hoppe, U. C.
(2009). Percutaneous Mitral Annuloplasty for Functional Mitral Regurgitation: Results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation
120: 326-333
[Abstract][Full Text]
Janousek, J, Gebauer, R A, Abdul-Khaliq, H, Turner, M, Kornyei, L, Grollmuss, O, Rosenthal, E, Villain, E, Fruh, A, Paul, T, Blom, N A, Happonen, J-M, Bauersfeld, U, Jacobsen, J R, van den Heuvel, F, Delhaas, T, Papagiannis, J, Trigo, C, for the Working Group for Cardiac Dysrhythmias and,
(2009). Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates. Heart
95: 1165-1171
[Abstract][Full Text]
Maruskova, M., Gregor, P., Bartunek, J., Tintera, J., Penicka, M.
(2009). Myocardial viability and cardiac dyssynchrony as strong predictors of perioperative mortality in high-risk patients with ischemic cardiomyopathy having coronary artery bypass surgery. J. Thorac. Cardiovasc. Surg.
138: 62-68
[Abstract][Full Text]
Baliga, V., Sapsford, R.
(2009). Review article: Diabetes mellitus and heart failure -- an overview of epidemiology and management. Diabetes and Vascular Disease Research
6: 164-171
[Abstract]
Sonne, C., Sugeng, L., Takeuchi, M., Weinert, L., Childers, R., Watanabe, N., Yoshida, K., Mor-Avi, V., Lang, R. M.
(2009). Real-Time 3-Dimensional Echocardiographic Assessment of Left Ventricular Dyssynchrony: Pitfalls in Patients With Dilated Cardiomyopathy. J Am Coll Cardiol Img
2: 802-812
[Abstract][Full Text]
Gervais, R., Leclercq, C., Shankar, A., Jacobs, S., Eiskjaer, H., Johannessen, A., Freemantle, N., Cleland, J. G.F., Tavazzi, L., Daubert, C., on behalf of the CARE-HF investigators,
(2009). Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial. Eur J Heart Fail
11: 699-705
[Abstract][Full Text]
Boriani, G., Bertini, M., Diemberger, I., Biffi, M., Martignani, C.
(2009). The QRS interval in patients treated with resynchronization therapy: which value?. Eur J Heart Fail
11: 635-637
[Full Text]
Hoppe, U C, Vanderheyden, M, Sievert, H, Brandt, M C, Tobar, R, Wijns, W, Rozenman, Y
(2009). Chronic monitoring of pulmonary artery pressure in patients with severe heart failure: multicentre experience of the monitoring Pulmonary Artery Pressure by Implantable device Responding to Ultrasonic Signal (PAPIRUS) II study. Heart
95: 1091-1097
[Abstract][Full Text]
Lancellotti, P., Senechal, M., Moonen, M., Donal, E., Magne, J., Nellessen, E., Attena, E., Cosyns, B., Melon, P., Pierard, L.
(2009). Myocardial contractile reserve during exercise predicts left ventricular reverse remodelling after cardiac resynchronization therapy. Eur J Echocardiogr
10: 663-668
[Abstract][Full Text]
Zhang, Q, van Bommel, R J, Fung, J W-H, Chan, J Y-S, Bleeker, G B, Ypenburg, C, Yip, G, Liang, Y-j, Schalij, M J, Bax, J J, Yu, C-M
(2009). Tissue Doppler velocity is superior to strain imaging in predicting long-term cardiovascular events after cardiac resynchronisation therapy. Heart
95: 1085-1090
[Abstract][Full Text]
Gademan, M. G. J., van Bommel, R. J., Borleffs, C. J. W., Man, S., Haest, J. C. W., Schalij, M. J., van der Wall, E. E., Bax, J. J., Swenne, C. A.
(2009). Biventricular pacing-induced acute response in baroreflex sensitivity has predictive value for midterm response to cardiac resynchronization therapy. Am. J. Physiol. Heart Circ. Physiol.
297: H233-H237
[Abstract][Full Text]
Garnier, A., Girod, G.
(2009). Cardiac re-synchronization therapy in a patient with isolated ventricular non-compaction: a case report. Eur J Echocardiogr
10: 713-715
[Abstract][Full Text]
Patwala, A. Y., Woods, P. R., Sharp, L., Goldspink, D. F., Tan, L. B., Wright, D. J.
(2009). Maximizing Patient Benefit From Cardiac Resynchronization Therapy With the Addition of Structured Exercise Training: A Randomized Controlled Study. J Am Coll Cardiol
53: 2332-2339
[Abstract][Full Text]
Gheorghiade, M., Pang, P. S.
(2009). Are BNP Changes During Hospitalization for Heart Failure a Reliable Surrogate for Predicting the Effects of Therapies on Post-Discharge Mortality?. J Am Coll Cardiol
53: 2349-2352
[Full Text]
Agricola, E., Ielasi, A., Oppizzi, M., Faggiano, P., Ferri, L., Calabrese, A., Vizzardi, E., Alfieri, O., Margonato, A.
(2009). Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction. Eur J Heart Fail
11: 581-587
[Abstract][Full Text]
Bax, J. J., Gorcsan, J. III
(2009). Echocardiography and noninvasive imaging in cardiac resynchronization therapy: results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) study in perspective.. J Am Coll Cardiol
53: 1933-1943
[Full Text]
Hawkins, N. M., Petrie, M. C., Burgess, M. I., McMurray, J. J.V.
(2009). Selecting patients for cardiac resynchronization therapy: the fallacy of echocardiographic dyssynchrony.. J Am Coll Cardiol
53: 1944-1959
[Abstract][Full Text]
Sanderson, J. E.
(2009). Echocardiography for cardiac resynchronization therapy selection: fatally flawed or misjudged?. J Am Coll Cardiol
53: 1960-1964
[Abstract][Full Text]
Anter, E., Jessup, M., Callans, D. J.
(2009). Atrial Fibrillation and Heart Failure: Treatment Considerations for a Dual Epidemic. Circulation
119: 2516-2525
[Full Text]
Boveda, S., Marijon, E., Jacob, S., Defaye, P., Winter, J. B., Bulava, A., Gras, D., Albenque, J. P., Combes, N., Pavin, D., Delarche, N., Teubl, A., Lambiez, M., Chevalier, P., on behalf of the Mona Lisa Study Group,
(2009). Incidence and prognostic significance of sustained ventricular tachycardias in heart failure patients implanted with biventricular pacemakers without a back-up defibrillator: results from the prospective, multicentre, Mona Lisa cohort study. Eur Heart J
30: 1237-1244
[Abstract][Full Text]
Buss, S. J., Humpert, P. M., Bekeredjian, R., Hardt, S. E., Zugck, C., Schellberg, D., Bauer, A., Filusch, A., Kuecherer, H., Katus, H. A., Korosoglou, G.
(2009). Echocardiographic phase imaging to predict reverse remodeling after cardiac resynchronization therapy.. J Am Coll Cardiol Img
2: 535-543
[Abstract][Full Text]
Boogers, M. M., Van Kriekinge, S. D., Henneman, M. M., Ypenburg, C., Van Bommel, R. J., Boersma, E., Dibbets-Schneider, P., Stokkel, M. P., Schalij, M. J., Berman, D. S., Germano, G., Bax, J. J.
(2009). Quantitative Gated SPECT-Derived Phase Analysis on Gated Myocardial Perfusion SPECT Detects Left Ventricular Dyssynchrony and Predicts Response to Cardiac Resynchronization Therapy. JNM
50: 718-725
[Abstract][Full Text]
Baruah, R., Manisty, C. H., Giannoni, A., Willson, K., Mebrate, Y., Baksi, A. J., Unsworth, B., Hadjiloizou, N., Sutton, R., Mayet, J., Francis, D. P.
(2009). Novel Use of Cardiac Pacemakers in Heart Failure to Dynamically Manipulate the Respiratory System Through Algorithmic Changes in Cardiac Output. Circ Heart Fail
2: 166-174
[Abstract][Full Text]
Ghio, S., Freemantle, N., Scelsi, L., Serio, A., Magrini, G., Pasotti, M., Shankar, A., Cleland, J. G.F., Tavazzi, L.
(2009). Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial. Eur J Heart Fail
11: 480-488
[Abstract][Full Text]
Borleffs, C. J. W., van Bommel, R. J., Molhoek, S. G., de Leeuw, J. G., Schalij, M. J., van Erven, L.
(2009). Requirement for coronary sinus lead interventions and effectiveness of endovascular replacement during long-term follow-up after implantation of a resynchronization device. Europace
11: 607-611
[Abstract][Full Text]
Tomlinson, D. R., Bashir, Y., Betts, T. R., Rajappan, K.
(2009). Accuracy of manual QRS duration assessment: its importance in patient selection for cardiac resynchronization and implantable cardioverter defibrillator therapy. Europace
11: 638-642
[Abstract][Full Text]
Malik, M.
(2009). Precise electrocardiographic measurements and clinical sense. Europace
11: 550-553
[Full Text]
Cubbon, R. M, Witte, K. K A
(2009). Cardiac resynchronisation therapy for chronic heart failure and conduction delay. BMJ
338: b1265-b1265
[Full Text]
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W.
(2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol
53: e1-e90
[Full Text]
Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W.
(2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol
53: 1343-1382
[Full Text]